)
Zoetis (ZTS) investor relations material
Zoetis Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Revenue for Q1 2026 was $2.3 billion, up 3% year-over-year, with adjusted net income of $646 million, up 2%, and adjusted diluted EPS of $1.53, up 9% on a reported basis.
Organic operational revenue was flat year-over-year, with adjusted net income up 1%.
International segment revenue grew 17% reported and 10% organically, while U.S. revenue declined 8% due to softer demand and increased competition in companion animal products.
Livestock revenue grew 12% organically, while companion animal revenue declined 4% organically amid intensified competition and price sensitivity.
The company implemented a major accounting change aligning international subsidiary reporting periods, impacting quarterly comparability.
Financial highlights
Q1 2026 revenue: $2.3 billion (+3% year-over-year); adjusted net income: $646 million (+2%); adjusted diluted EPS: $1.53 (+9%).
Adjusted gross margin was 71.8%, nearly flat year-over-year; U.S. gross margin was 82.2%, International 70.9%.
Adjusted cost of sales was $638 million (28.2% of revenue); adjusted SG&A expenses were $585 million; adjusted R&D expenses were $179 million.
Interest expense increased to $62 million due to higher average debt balances.
Net cash provided by operating activities was $401 million, down from $515 million in Q1 2025, mainly due to timing of receipts/payments and higher inventory build-up.
Outlook and guidance
Full-year 2026 revenue guidance: $9.68–$9.96 billion; organic operational revenue growth expected at 2%–5%.
Adjusted net income guidance: $2.87–$2.95 billion (organic operational growth of 2%–6%).
Adjusted diluted EPS guidance: $6.85–$7.00; reported diluted EPS: $6.35–$6.50.
Fiscal year alignment provides a 200–250 bps tailwind, but challenging environment offsets this.
Adjusted cost of sales as a percentage of revenue expected at ~28.5% for 2026.
- Driving animal health innovation and growth with a diverse portfolio and global scale.ZTS
Corporate presentation8 Apr 2026 - 2026 proxy details strong growth, governance, and sustainability, with key votes on directors and pay.ZTS
Proxy filing8 Apr 2026 - Key votes include director elections, say-on-pay, auditor ratification, and written consent rights.ZTS
Proxy filing8 Apr 2026 - Growth in 2026 will be led by parasiticides, innovation in long-acting therapies, and expanding franchises.ZTS
2026 KeyBanc Capital Markets Healthcare Forum17 Mar 2026 - Triple combination parasiticides and livestock drive growth amid resilient global demand.ZTS
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Strong product innovation and market expansion drive growth amid resilient pet health spending.ZTS
Leerink Global Healthcare Conference 20269 Mar 2026 - 2026 guidance reflects resilience, innovation, and a synchronized global reporting calendar.ZTS
BofA Securities Animal Health Summit26 Feb 2026 - 2025 saw 6% organic growth, robust franchises, and strong 2026 guidance for further gains.ZTS
Q4 202512 Feb 2026 - Strong Q1 growth, robust innovation pipeline, and expanding alternative channels drive outlook.ZTS
Stifel Jaws & Paws Conference 20253 Feb 2026
Next Zoetis earnings date
Next Zoetis earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage